![](../../files/images/goods/M30866.png)
Astragaloside
CAS No. 17429-69-5
Astragaloside ( —— )
产品货号. M30866 CAS No. 17429-69-5
Astragaloside may protect against brain contusion and neuronal apoptosis after TBI by attenuating microglia activation in male rats.
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
50MG | 获取报价 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Astragaloside
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Astragaloside may protect against brain contusion and neuronal apoptosis after TBI by attenuating microglia activation in male rats.
-
产品描述Astragaloside may protect against brain contusion and neuronal apoptosis after TBI by attenuating microglia activation in male rats. Astragalosides-induced apoptosis in NB4 cells may be associated with down-regulation of the expression of BCL-2 and NF-κB, finally the relative activity of caspase-3 activated. Astragaloside has several pharmacological actions on cardiovascular system, including positive inotropic, anti-arrhythmia and anti-oxidant activities; it also has anti-apoptotic activity, which may contribute to the improvement of clinical outcomes in treating myocarditis with pharmaceutics of Astragalus membranaceus.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Bcl-2/Bax | NF-kB | Caspase | NO | NOS | Trk receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number17429-69-5
-
分子量640.55
-
分子式C28H32O17
-
纯度>98% (HPLC)
-
溶解度DMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/new12.jpg)
![](/themes/theme/en/images/gift.jpg)
![](/themes/theme/en/images/ct2.png)
关联产品
-
m-Methoxyphenol
3-Hydroxyanisole is an agent of biochemical.
-
Pyridoxal hydrochlor...
维生素 B6 的 4-甲醛形式,可转化为磷酸吡哆醛,磷酸吡哆醛是合成氨基酸、神经递质(血清素、去甲肾上腺素)、鞘脂、氨基乙酰丙酸的辅酶。
-
RG 13022
RG13022 是一种酪氨酸激酶抑制剂;抑制 EGF 受体的自磷酸化反应(IC50:4 μM)。